Tuesday, August 14, 2018

Vitamin E hydroquinone is an endogenous regulator of ferroptosis via redox control of 15-lipoxygenase

›
Hinman A, Holst CR, Latham JC, Bruegger JJ, Ulas G, McCusker KP, et al. (2018) Vitamin E hydroquinone is an endogenous regulator of ferropto...

Genetic basis of hypertrophic cardiomyopathy in children

›
tefan Rupp, Moataz Felimban, Anne Schänzer, Dietmar Schranz, Christoph Marschall, Martin Zenker, Thushiha Logeswaran, Christoph Neuhäuser, J...
Monday, August 13, 2018

Nonataxia symptoms in Friedreich Ataxia. Report from the Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)

›
Kathrin Reetz, Imis Dogan, Christian Hohenfeld, Claire Didszun, Paola Giunti, Caterina Mariotti, Alexandra Durr, Sylvia Boesch, Thomas Klops...
Friday, August 10, 2018

Gene therapy for neurological disorders: progress and prospects

›
Benjamin E. Deverman, Bernard M. Ravina, Krystof S. Bankiewicz, Steven M. Paul & Dinah W. Y. Sah; Nature Reviews Drug Discovery, Publish...
Friday, August 3, 2018

Longitudinal analysis of contrast acuity in Friedreich ataxia

›
Ali G. Hamedani, Lauren A. Hauser, Susan Perlman, Katherine Mathews, George R. Wilmot, Theresa Zesiewicz, S.H. Subramony, Tetsuo Ashizawa, M...

Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration

›
Abdalkader M, Lampinen R, Kanninen KM, Malm TM, Liddell JR. Front Neurosci. 2018;12 . PMCID: PMC6048292. Ferroptosis is a newly described ...

Novoheart, Pfizer develop 3-D model of Friedreich ataxia

›
VANCOUVER, British Columbia – June 25, 2018 (GLOBE NEWSWIRE) – Novoheart (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) is pleased to ...
Wednesday, August 1, 2018

The Effects of Game Based Exercise Training on Balance and Postural Control in Patients With Ataxia

›
ClinicalTrials.gov Identifier: NCT03607058 Patients who meet the inclusion criteria will be divided into two groups randomly: 'Kinect ...
Saturday, July 28, 2018

Public offering nets $203mm for Reata

›
Strategic Transactions. Jul 2018 Executive Summary Reata Pharmaceuticals Inc. (developing drugs targeting molecular pathways that regulate...

Double-blind, randomized and controlled trial of EPI-743 in Friedreich's ataxia

›
Theresa Zesiewicz, Jason L Salemi, Susan Perlman, Kelly L Sullivan, Jessica D Shaw, Yangxin Huang, Charles Isaacs, Clifton Gooch, David R Ly...